Results 81 to 90 of about 44,958 (207)

A practical, adaptive compliance management framework for improving marine protected area effectiveness

open access: yesConservation Biology, EarlyView.
Abstract Noncompliance regularly undermines the effectiveness of marine protected areas (MPAs) worldwide. The reasons for and drivers of noncompliance depend on the context (e.g., insufficient funding, capacity, neocolonialism, historical conflict), but the prevalent solution offered to curtail noncompliance tends to be more or better enforcement.
B. Bergseth   +10 more
wiley   +1 more source

Realizing and assessing social successes in invasive species management

open access: yesConservation Science and Practice, EarlyView.
Abstract Each year untold numbers of land managers and volunteers work individually and collectively to manage invasive plant, animal, and insect species. Whether such efforts are deemed successful depends on ecological and economic outcomes, with limited consideration of the social processes, costs, and benefits.
Sonia Graham   +6 more
wiley   +1 more source

A Wider View: Amie Siegel's Panorama and the Role of Contemporary Art in Natural History Museum Critique and Practice

open access: yesCurator: The Museum Journal, EarlyView.
ABSTRACT In Panorama, artist Amie Siegel montaged films made by Carnegie Museum of Natural History (CMNH) staff in the 1930s–1970s when documenting their research expeditions and exhibition projects, along with her own footage shot in the museum. Displayed at Carnegie Museum of Art in 2023–2024, the exhibition made visible the often hidden labors of ...
Deirdre Madeleine Smith
wiley   +1 more source

Cost‐Effectiveness of Venetoclax‐Based Treatment in Treatment‐Naïve Fit Patients With CLL Without TP53 Aberrations

open access: yesEuropean Journal of Haematology, EarlyView.
ABSTRACT The GAIA‐CLL13 trial showed that venetoclax‐obinutuzumab (Ven‐O) based regimens, with or without ibrutinib, offer superior efficacy compared to chemoimmunotherapy (CIT) with regards to progression free survival (PFS) in fit, treatment‐naïve (TN) CLL patients. However, their higher costs warrant a cost‐effectiveness evaluation.
Lars Holger Ehlers   +6 more
wiley   +1 more source

Galápagos and Californian sea lions are separate species: Genetic analysis of the genus Zalophus and its implications for conservation management

open access: yesFrontiers in Zoology, 2007
Background Accurate formal taxonomic designations are thought to be of critical importance for the conservation of endangered taxa. The Galápagos sea lion (GSL), being appreciated as a key element of the Galápagos marine ecosystem, has lately been listed
Wolf Jochen BW   +2 more
doaj   +1 more source

Inequities in inflammatory bowel disease care: a Tasmanian case study with proposed solutions

open access: yesInternal Medicine Journal, EarlyView.
Abstract There is well‐recognised inequity of care for people treated with inflammatory bowel disease (IBD) between metropolitan and regional areas. We aim to describe these barriers to care using Tasmania as a case example and to suggest solutions for addressing these barriers that can be used in Tasmania and beyond.
Alexander T Elford   +8 more
wiley   +1 more source

Addiction and chronic skin diseases: A Pan‐European study on prevalence, associations and patient impact

open access: yesJournal of the European Academy of Dermatology and Venereology, EarlyView.
This pan‐European study reveals high rates of addiction in patients with chronic skin diseases. Smoking, alcohol, drug use, gambling, and internet addiction were prevalent and associated with quality of life, demographics, and region. The findings support integrating addiction screening into dermatologic care to improve outcomes.
Stefanie Ziehfreund   +73 more
wiley   +1 more source

French guidelines on systemic treatments for moderate‐to‐severe psoriasis in adults: Update 2025

open access: yesJournal of the European Academy of Dermatology and Venereology, EarlyView.
New 2025 French guidelines update psoriasis management with revised algorithms integrating recent systemic therapies. They recommend methotrexate, adalimumab or ustekinumab as first‐line treatments and provide guidance for special psoriasis forms, comorbidities, pregnancy and long‐term management.
Marie Masson Regnault   +51 more
wiley   +1 more source

Nemolizumab in prurigo nodularis up to 100 weeks: OLYMPIA LTE interim analysis

open access: yesJournal of the European Academy of Dermatology and Venereology, EarlyView.
In this interim analysis of the OLYMPIA long‐term extension trial, nemolizumab exhibited sustained efficacy and was well tolerated through 100 weeks, with most adverse events being mild/moderate. Patients showed clinically meaningful improvements in core signs and symptoms.
Franz J. Legat   +22 more
wiley   +1 more source

Home - About - Disclaimer - Privacy